VENCLEXTA (ven-KLEKS-tuh) and rituximab (ri-TUKS-i-mab) are two different prescription medications

VENCLEXTA is an oral (taken by mouth) medication.

Rituximab is an intravenous (IV) infusion. 

Your healthcare provider may prescribe VENCLEXTA alone or in combination with rituximab. The decision is between you and your healthcare provider.
 

 
Who is VENCLEXTA + rituximab for? 

VENCLEXTA + rituximab is used to treat people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), with or without 17p deletion, who have tried at least one other therapy. Learn more about 17p deletion here.
 

 
After approximately 2 years, your healthcare provider can stop your VENCLEXTA treatment.